SCHEMBL165779

SCHEMBL165779

NC(=O)Oc1ccc(CNC(=O)Nc2ccc(S(=O)(=O)N3CCCCC3)cc2)cn1

nearest known ligand 0.71

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 20/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL164697 0.87 NAMPT (0.78) NAMPT
SCHEMBL15311086 0.87 NAMPT (0.70) NAMPT
SCHEMBL166633 0.85 NAMPT (0.75) NAMPT
SCHEMBL22402280 0.84 NAMPT (0.79) NAMPT
SCHEMBL15316700 0.83 NAMPT (0.81) NAMPT
SCHEMBL164407 0.83 NAMPT (1.00) NAMPT
SCHEMBL29635876 0.83 NAMPT (1.00) NAMPT
SCHEMBL165218 0.82 NAMPT (1.00) NAMPT
SCHEMBL17727636 0.82 NAMPT (0.76) NAMPT
SCHEMBL162000 0.81 NAMPT (1.00) NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611777-A1 4- { [ ( PYRIDIN- 3 - YL -METHYL) AMINOCARBONYL]AMINO} BENZENE - SULFONE DERIVATIVES AS NAMPT INHIBITORS FOR THERAPY OF DISEASES SUCH AS CANCER Forma TM, LLC. (US) 2013-07-10 EP disclosed
WO-2012031196-A1 4- { [ ( PYRIDIN- 3 - YL -METHYL) AMINOCARBONYL] AMINO} BENZENE - SULFONE DERIVATIVES AS NAMPT INHIBITORS FOR THERAPY OF DISEASES SUCH AS CANCER FORMA THERAPEUTICS, INC. (US) 2012-03-08 WO disclosed